Short Interest in Bioxytran, Inc. (OTCMKTS:BIXT) Drops By 86.7%

Bioxytran, Inc. (OTCMKTS:BIXT) saw a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 10,300 shares, a drop of 86.7% from the December 31st total of 77,600 shares. Based on an average trading volume of 153,100 shares, the days-to-cover ratio is currently 0.1 days.

Bioxytran Stock Up 3.4 %

OTCMKTS:BIXT traded up $0.00 on Thursday, reaching $0.10. 56,000 shares of the company’s stock were exchanged, compared to its average volume of 227,700. The business has a fifty day moving average of $0.09 and a 200-day moving average of $0.10. Bioxytran has a 52-week low of $0.06 and a 52-week high of $0.15. The firm has a market capitalization of $8.68 million, a price-to-earnings ratio of -10.00 and a beta of -0.55.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.